High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma.
about
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib.Antineoplastic drugs and their analysis: a state of the art review.Therapeutic drug monitoring and tyrosine kinase inhibitors.Drug interaction between tacrolimus and nilotinib in a patient with chronic myeloid leukemia after renal transplant.Bile acid is important for gastrointestinal absorption of nilotinib.
P2860
High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-performance liquid chroma ...... of nilotinib in human plasma.
@ast
High-performance liquid chroma ...... of nilotinib in human plasma.
@en
type
label
High-performance liquid chroma ...... of nilotinib in human plasma.
@ast
High-performance liquid chroma ...... of nilotinib in human plasma.
@en
prefLabel
High-performance liquid chroma ...... of nilotinib in human plasma.
@ast
High-performance liquid chroma ...... of nilotinib in human plasma.
@en
P2093
P356
P1476
High-performance liquid chroma ...... of nilotinib in human plasma.
@en
P2093
Ken-ichi Sawada
Masatomo Miura
Naoto Takahashi
P304
P356
10.1002/BMC.1364
P577
2010-07-01T00:00:00Z